Clinical Trials Directory

Trials / Completed

CompletedNCT00994474

Comparison of Outcome Parameters in Laser Rhytide Treatment

Comparison of Clinical Outcome Parameters, the Patient Benefit Index (PBI) and Patient Satisfaction After Ablative Fractional Laser Treatment of Peri-orbital Rhytides

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
28 (actual)
Sponsor
Laserklinik Karlsruhe · Academic / Other
Sex
All
Age
40 Years – 55 Years
Healthy volunteers
Accepted

Summary

We previously published a comparative split-face study which has shown a significant, albeit moderate, effect of ablative fractional laser treatment. While indicating that a single session with fractional ablative lasers can be effective in the treatment of peri-orbital wrinkles, the trial also revealed substantial disagreement between the different end points (profilometry, Fitzpatrick wrinkle score, patient satisfaction). Since the PBI is a patient-related index it could not be included in the aforementioned split-face trial; the present study therefore attempts to further elucidate the patient-related benefit of a single fractional ablative laser treatment session as well as carefully analyse the respective correlations between the outcome parameters employed.

Conditions

Interventions

TypeNameDescription
PROCEDUREFractional carbon dioxide laser treatmentWith the CO2 laser (Fraxel Re:pair, Solta Medical Inc., Hayward, CA), patients received two passes at 15 mJ (1st pass) and 20 mJ (2nd pass), respectively, with a total density of 20 %. We employed 'pin-point bleeding' and serosanguinous exudate as a clinical end point. The pulse duration was 10 msec.
PROCEDUREFractional Er:YAG laser treatmentThe Er:YAG laser (MCL 30 Dermablate, Asclepion Laser Technologies GmbH, Jena, Germany) was used in 4 passes with a total fluence of 60 J/cm² and pulse stacking (6 stacked pulses); the pulse duration was 400 μsec.

Timeline

Start date
2008-08-01
Primary completion
2009-03-01
Completion
2009-03-01
First posted
2009-10-14
Last updated
2009-10-14

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00994474. Inclusion in this directory is not an endorsement.